{"transactions":[{"id":4613271,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-09T20:12:12.000Z","date":"2026-09-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":5116,"price":3.4275,"value":17535.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Withholding of shares to pay the tax liability associated with vesting of restricted shares."}],"balance_after":204598,"source":{"system":"sec-edgar","filing":"0001470831-26-000880","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719325/000147083126000880/form4.xml","form_type":"4"}},{"id":748507,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:01:08.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":46106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors."}],"balance_after":209714,"source":{"system":"sec-edgar","filing":"0001470831-26-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000147083126000517/form4.xml","form_type":"4"}},{"id":752823,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T23:48:01.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":15970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":15970,"derivative":{"exercise_price":0,"exercise_date":"2027-06-01","underlying":"Common Stock","underlying_shares":15970},"source":{"system":"sec-edgar","filing":"0001628280-26-040581","document":"wk-form4_1780530479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040581/wk-form4_1780530479.xml","form_type":"4"}},{"id":752822,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-06-03T23:48:01.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":11069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11069,"derivative":{"exercise_price":10.52,"exercise_date":"2027-06-01","expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":11069},"source":{"system":"sec-edgar","filing":"0001628280-26-040581","document":"wk-form4_1780530479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040581/wk-form4_1780530479.xml","form_type":"4"}},{"id":752821,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T23:48:01.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":5893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":5893},"source":{"system":"sec-edgar","filing":"0001628280-26-040581","document":"wk-form4_1780530479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040581/wk-form4_1780530479.xml","form_type":"4"}},{"id":752820,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T23:48:01.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":5893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":5893,"source":{"system":"sec-edgar","filing":"0001628280-26-040581","document":"wk-form4_1780530479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040581/wk-form4_1780530479.xml","form_type":"4"}},{"id":770119,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:05:27.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":251185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":251185,"derivative":{"exercise_price":0.8539,"expiration_date":"2036-05-18","underlying":"Class A Common Stock","underlying_shares":251185},"source":{"system":"sec-edgar","filing":"0001140361-26-022243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036126022243/form4.xml","form_type":"4"}},{"id":953062,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-05T23:15:43.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":5893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":5893,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":5893},"source":{"system":"sec-edgar","filing":"0001628280-26-000706","document":"wk-form4_1767654937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026000706/wk-form4_1767654937.xml","form_type":"4"}},{"id":953061,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-01-05T23:15:43.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":4171,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4171,"derivative":{"exercise_price":11.76,"exercise_date":"2026-06-01","expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":4171},"source":{"system":"sec-edgar","filing":"0001628280-26-000706","document":"wk-form4_1767654937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026000706/wk-form4_1767654937.xml","form_type":"4"}},{"id":962331,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-19T21:08:48.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":10286,"price":2.46,"value":25303.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan in lieu of cash fees with immediate vesting."}],"balance_after":163608,"source":{"system":"sec-edgar","filing":"0001470831-25-000448","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000147083125000448/form4.xml","form_type":"4"}},{"id":1031872,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-26T20:26:58.000Z","date":"2025-09-24","kind":"grant","planned":false,"acquired":true,"shares":6118,"price":3.269,"value":19999.742,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan in lieu of cash fees with immediate vesting."}],"balance_after":153322,"source":{"system":"sec-edgar","filing":"0001470831-25-000232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000147083125000232/form4.xml","form_type":"4"}},{"id":1101899,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-25T20:09:42.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":6657,"price":3.0082,"value":20025.5874,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan in lieu of cash fees with immediate vesting."}],"balance_after":147204,"source":{"system":"sec-edgar","filing":"0001062993-25-012140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000106299325012140/form4.xml","form_type":"4"}},{"id":1139106,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-21T20:01:36.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":126095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":126095,"derivative":{"exercise_price":1.41,"expiration_date":"2035-05-19","underlying":"Class A Common Stock","underlying_shares":126095},"source":{"system":"sec-edgar","filing":"0001140361-25-020048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036125020048/form4.xml","form_type":"4"}},{"id":1147846,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:46:39.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":71017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) May 14, 2026, or (ii) immediately prior to the commencement of the Company's 2026 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors."}],"balance_after":140547,"source":{"system":"sec-edgar","filing":"0001062993-25-009567","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000106299325009567/form4.xml","form_type":"4"}},{"id":1190044,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-27T20:01:19.000Z","date":"2025-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1385,"price":3.5525,"value":4920.2125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Withholding of shares to pay the tax liability associated with vesting of restricted shares."}],"balance_after":69530,"source":{"system":"sec-edgar","filing":"0001062993-25-006390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000106299325006390/form4.xml","form_type":"4"}},{"id":1241375,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-28T02:14:37.000Z","date":"2025-02-27","kind":"purchase","planned":false,"acquired":true,"shares":47659,"price":3.1729,"value":151217.2411,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased in the open market on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.08 to $3.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":70915,"source":{"system":"sec-edgar","filing":"0001062993-25-003842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000106299325003842/form4.xml","form_type":"4"}},{"id":1411058,"issuer":{"id":6152,"kind":"organization","name":"ORASURE TECHNOLOGIES INC","symbol":"OSUR"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T20:31:06.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":23256,"price":4.3,"value":100000.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on September 6, 2026. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors."}],"balance_after":23256,"source":{"system":"sec-edgar","filing":"0001062993-24-016411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116463/000106299324016411/form4.xml","form_type":"4"}},{"id":1511639,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T20:46:45.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":113281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Kenny's continued service through the applicable vesting date."}],"balance_after":113281,"derivative":{"exercise_price":1.86,"expiration_date":"2034-05-16","underlying":"Class A Common Stock","underlying_shares":113281},"source":{"system":"sec-edgar","filing":"0001140361-24-026707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124026707/form4.xml","form_type":"4"}},{"id":1711874,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2023-12-14T22:10:31.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"}],"balance_after":75000,"derivative":{"exercise_price":1.01,"exercise_date":"2024-12-13","expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-23-044909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044909/ownership.xml","form_type":"4"}},{"id":1717257,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2023-12-11T22:21:47.000Z","date":"2023-08-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options granted to Mr. Kenny in August 2023 as a new Board member. Final issuance of the options was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not Applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vesting on 12/7/2023, 25% on 12/07/2024, 25% on 12/07/2025 and 25% on 12/07/2026"}],"balance_after":30000,"derivative":{"exercise_price":1.25,"expiration_date":"2033-08-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-044438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044438/ownership.xml","form_type":"4"}},{"id":1879864,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-05-24T20:18:31.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":114285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on May 22, 2024, subject to Mr. Kenny's continued service through the applicable vesting date."}],"balance_after":114285,"source":{"system":"sec-edgar","filing":"0001140361-23-026411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123026411/form4.xml","form_type":"4"}},{"id":2040986,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:12:52.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":82940,"price":15.12,"value":1254052.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":18.88,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":82940},"source":{"system":"sec-edgar","filing":"0001567619-23-001530","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001530/doc1.xml","form_type":"4"}},{"id":2040985,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:12:52.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":83535,"price":15.52,"value":1296463.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":18.48,"expiration_date":"2030-11-05","underlying":"Common Stock","underlying_shares":83535},"source":{"system":"sec-edgar","filing":"0001567619-23-001530","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001530/doc1.xml","form_type":"4"}},{"id":2040984,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-31T14:12:52.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":66039,"price":23.9,"value":1578332.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment."}],"balance_after":0,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":66039},"source":{"system":"sec-edgar","filing":"0001567619-23-001530","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001530/doc1.xml","form_type":"4"}},{"id":2040983,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-31T14:12:52.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":267651,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the \"Merger Agreement\") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-23-001530","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001530/doc1.xml","form_type":"4"}},{"id":2040982,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-31T14:12:52.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":47060,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 47,060 shares of the Issuer's common stock awarded to the Reporting Person upon the vesting of a portion of an award of performance stock units (\"PSUs\") in connection with the closing of the transactions contemplated by the Merger Agreement (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents 47,060 shares of the Issuer's common stock awarded to the Reporting Person upon the vesting of a portion of an award of performance stock units (\"PSUs\") in connection with the closing of the transactions contemplated by the Merger Agreement (as defined below)."}],"balance_after":267651,"source":{"system":"sec-edgar","filing":"0001567619-23-001530","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000156761923001530/doc1.xml","form_type":"4"}},{"id":2122882,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-08T14:25:59.000Z","date":"2022-11-04","kind":"tax_withholding","acquired":false,"shares":4271,"price":32.01,"value":136714.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent restricted stock units withheld by the Company under the net share settlement method to cover certain taxes due upon vesting of units granted on November 4, 2021."}],"balance_after":220591,"source":{"system":"sec-edgar","filing":"0001127602-22-025087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222025087/form4.xml","form_type":"4"}},{"id":2143057,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-05T15:54:06.000Z","date":"2022-10-03","kind":"tax_withholding","acquired":false,"shares":40269,"price":31.53,"value":1269681.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent restricted stock units withheld by the Company under the net share settlement method to cover certain taxes due upon vesting of units granted on November 15, 2021."}],"balance_after":224862,"source":{"system":"sec-edgar","filing":"0001127602-22-023690","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222023690/form4.xml","form_type":"4"}},{"id":2220604,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-28T09:42:43.000Z","date":"2022-06-27","kind":"exercise","acquired":false,"shares":61437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":66039,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":61437},"source":{"system":"sec-edgar","filing":"0001127602-22-018184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018184/form4.xml","form_type":"4"}},{"id":2220603,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-28T09:42:43.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":13559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":127476,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":13559},"source":{"system":"sec-edgar","filing":"0001127602-22-018184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018184/form4.xml","form_type":"4"}},{"id":2220602,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-28T09:42:43.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":61437,"price":30.3854,"value":1866787.8198,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.76. The Reporting Person undertakes to provide full pricing information if requested by the Securities and\nExchange Commission, the issuer or a security holder of the issuer."}],"balance_after":265131,"source":{"system":"sec-edgar","filing":"0001127602-22-018184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018184/form4.xml","form_type":"4"}},{"id":2220601,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-28T09:42:43.000Z","date":"2022-06-27","kind":"exercise","acquired":true,"shares":61437,"price":10.1,"value":620513.7,"ownership":{"direct":true},"balance_after":326568,"source":{"system":"sec-edgar","filing":"0001127602-22-018184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018184/form4.xml","form_type":"4"}},{"id":2220600,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-28T09:42:43.000Z","date":"2022-06-24","kind":"sale","acquired":false,"shares":13559,"price":30.0049,"value":406836.4391,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.11. The Reporting Person undertakes to provide full pricing information if requested by the Securities and\nExchange Commission, the issuer or a security holder of the issuer."}],"balance_after":265131,"source":{"system":"sec-edgar","filing":"0001127602-22-018184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018184/form4.xml","form_type":"4"}},{"id":2220599,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-28T09:42:43.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":13559,"price":10.1,"value":136945.9,"ownership":{"direct":true},"balance_after":278690,"source":{"system":"sec-edgar","filing":"0001127602-22-018184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018184/form4.xml","form_type":"4"}},{"id":2222488,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-23","kind":"exercise","acquired":false,"shares":14607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":141035,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":14607},"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222487,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-23","kind":"exercise","acquired":false,"shares":5349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan upon Mr. Kenny being hired as Chief Executive Officer. The options vested in four (4) equal installments from the date of grant until fully vested on October 9, 2021."}],"balance_after":0,"derivative":{"exercise_price":14.5,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":5349},"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222486,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-22","kind":"exercise","acquired":false,"shares":44651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan upon Mr. Kenny being hired as Chief Executive Officer. The options vested in four (4) equal installments from the date of grant until fully vested on October 9, 2021."}],"balance_after":5349,"derivative":{"exercise_price":14.5,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":44651},"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222485,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-23","kind":"sale","acquired":false,"shares":19956,"price":29.9764,"value":598209.0384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $29.61 to $30.13. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":265131,"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222484,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-23","kind":"exercise","acquired":true,"shares":14607,"price":10.1,"value":147530.7,"ownership":{"direct":true},"balance_after":285087,"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222483,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-23","kind":"exercise","acquired":true,"shares":5349,"price":14.5,"value":77560.5,"ownership":{"direct":true},"balance_after":270480,"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222482,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-22","kind":"sale","acquired":false,"shares":44651,"price":29.7176,"value":1326920.5576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $29.50 to $29.94. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":265131,"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2222481,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-24T12:33:19.000Z","date":"2022-06-22","kind":"exercise","acquired":true,"shares":44651,"price":14.5,"value":647439.5,"ownership":{"direct":true},"balance_after":309782,"source":{"system":"sec-edgar","filing":"0001127602-22-018097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760222018097/form4.xml","form_type":"4"}},{"id":2511897,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-16T15:56:16.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":155511,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 99,505 on October 1, 2022; and (ii) 56,006 on November 15, 2023."}],"balance_after":265131,"source":{"system":"sec-edgar","filing":"0001127602-21-029297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221029297/form4.xml","form_type":"4"}},{"id":2511896,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-16T15:56:16.000Z","date":"2021-11-15","kind":"other","acquired":false,"shares":155511,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer."}],"balance_after":109620,"source":{"system":"sec-edgar","filing":"0001127602-21-029297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221029297/form4.xml","form_type":"4"}},{"id":2522130,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-11-08T16:06:43.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":82940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on November 4, 2022; and (ii) the remaining 75% of the options awarded vest pro rata each month from November 4, 2022 through November 4, 2025."}],"balance_after":82940,"derivative":{"exercise_price":18.88,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":82940},"source":{"system":"sec-edgar","filing":"0001127602-21-028572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221028572/form4.xml","form_type":"4"}},{"id":2522129,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-08T16:06:43.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":56472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on November 4, 2025)."}],"balance_after":265131,"source":{"system":"sec-edgar","filing":"0001127602-21-028572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221028572/form4.xml","form_type":"4"}},{"id":2780337,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-18T08:37:37.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":30000,"price":25,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 9, 2020."}],"balance_after":208659,"source":{"system":"sec-edgar","filing":"0001127602-21-011258","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221011258/form4.xml","form_type":"4"}},{"id":2795710,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-11T16:29:06.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":10000,"price":25,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 9, 2020."}],"balance_after":238659,"source":{"system":"sec-edgar","filing":"0001127602-21-010225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221010225/form4.xml","form_type":"4"}},{"id":2856740,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-17T10:14:51.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":2082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":155642,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":2082},"source":{"system":"sec-edgar","filing":"0001127602-21-006067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221006067/form4.xml","form_type":"4"}},{"id":2856739,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T10:14:51.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":2359,"price":30.3535,"value":71603.9065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prices range from $30.02 per share to $30.55 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":248659,"source":{"system":"sec-edgar","filing":"0001127602-21-006067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221006067/form4.xml","form_type":"4"}},{"id":2856738,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T10:14:51.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":2082,"price":10.1,"value":21028.2,"ownership":{"direct":true},"balance_after":251018,"source":{"system":"sec-edgar","filing":"0001127602-21-006067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221006067/form4.xml","form_type":"4"}},{"id":2860922,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-16T08:45:00.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":23097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":157724,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":23097},"source":{"system":"sec-edgar","filing":"0001127602-21-005607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221005607/form4.xml","form_type":"4"}},{"id":2860921,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-16T08:45:00.000Z","date":"2021-02-11","kind":"exercise","acquired":false,"shares":1164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":180821,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":1164},"source":{"system":"sec-edgar","filing":"0001127602-21-005607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221005607/form4.xml","form_type":"4"}},{"id":2860920,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-16T08:45:00.000Z","date":"2021-02-12","kind":"sale","acquired":false,"shares":26181,"price":30.1396,"value":789084.8676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Prices range from $30.00 per share to $30.49 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":248936,"source":{"system":"sec-edgar","filing":"0001127602-21-005607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221005607/form4.xml","form_type":"4"}},{"id":2860919,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-16T08:45:00.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":23097,"price":10.1,"value":233279.7,"ownership":{"direct":true},"balance_after":275117,"source":{"system":"sec-edgar","filing":"0001127602-21-005607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221005607/form4.xml","form_type":"4"}},{"id":2860918,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-16T08:45:00.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":1320,"price":30.0011,"value":39601.452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prices range from $30.00 per share to $30.015 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":252020,"source":{"system":"sec-edgar","filing":"0001127602-21-005607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221005607/form4.xml","form_type":"4"}},{"id":2860917,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-16T08:45:00.000Z","date":"2021-02-11","kind":"exercise","acquired":true,"shares":1164,"price":10.1,"value":11756.4,"ownership":{"direct":true},"balance_after":253340,"source":{"system":"sec-edgar","filing":"0001127602-21-005607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221005607/form4.xml","form_type":"4"}},{"id":2870343,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-10T13:22:10.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":16134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019.  The options vest on a pro rata basis over the three (3) years from the Agreement's effective date."}],"balance_after":181985,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":16134},"source":{"system":"sec-edgar","filing":"0001127602-21-004878","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004878/form4.xml","form_type":"4"}},{"id":2870342,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-10T13:22:10.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant until fully vested on October 9, 2021."}],"balance_after":50000,"derivative":{"exercise_price":14.5,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-21-004878","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004878/form4.xml","form_type":"4"}},{"id":2870341,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T13:22:10.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":68288,"price":29.8605,"value":2039113.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prices range from $25.26 per share to $30.35 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":252176,"source":{"system":"sec-edgar","filing":"0001127602-21-004878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004878/form4.xml","form_type":"4"}},{"id":2870340,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T13:22:10.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":16134,"price":10.1,"value":162953.4,"ownership":{"direct":true},"balance_after":320464,"source":{"system":"sec-edgar","filing":"0001127602-21-004878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004878/form4.xml","form_type":"4"}},{"id":2870339,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T13:22:10.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":50000,"price":14.5,"value":725000.0,"ownership":{"direct":true},"balance_after":304330,"source":{"system":"sec-edgar","filing":"0001127602-21-004878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004878/form4.xml","form_type":"4"}},{"id":2875621,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-08T10:18:49.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":20000,"price":25,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 9, 2020."}],"balance_after":254330,"source":{"system":"sec-edgar","filing":"0001127602-21-004268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004268/form4.xml","form_type":"4"}},{"id":2875620,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-08T10:18:49.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":20000,"price":25,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020."}],"balance_after":274330,"source":{"system":"sec-edgar","filing":"0001127602-21-004268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004268/form4.xml","form_type":"4"}},{"id":2988916,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-09T13:29:34.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":83535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on 11/15/2023."}],"balance_after":83535,"derivative":{"exercise_price":18.48,"expiration_date":"2030-11-05","underlying":"Common Stock","underlying_shares":83535},"source":{"system":"sec-edgar","filing":"0001127602-20-028458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220028458/form4.xml","form_type":"4"}},{"id":2988915,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-09T13:29:34.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":56006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on 11/15/2023."}],"balance_after":294330,"source":{"system":"sec-edgar","filing":"0001127602-20-028458","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220028458/form4.xml","form_type":"4"}},{"id":3212338,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-13T09:05:05.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":30000,"price":5.7847,"value":173541.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Prices range from $5.7300 per share to $5.7900 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":238324,"source":{"system":"sec-edgar","filing":"0001127602-20-010524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220010524/form4.xml","form_type":"4"}},{"id":3254818,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-24T11:01:11.000Z","date":"2020-02-21","kind":"purchase","acquired":true,"shares":10000,"price":7.6546,"value":76546.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Prices range from $7.6400 per share to $7.6700 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":208324,"source":{"system":"sec-edgar","filing":"0001127602-20-007112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220007112/form4.xml","form_type":"4"}},{"id":3375520,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-11-12T08:08:48.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":20000,"price":7.7294,"value":154588.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Prices range from $7.7104 per share to $7.7700 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":198324,"source":{"system":"sec-edgar","filing":"0001127602-19-032417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219032417/form4.xml","form_type":"4"}},{"id":3378096,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-11-07T15:03:35.000Z","date":"2019-11-05","kind":"grant","acquired":true,"shares":198119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This award is made under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019.  The options vest on a pro rata basis over the three (3) years following the Agreement's effective date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest on a pro rata basis over the three (3) years following the October 1, 2019 effective date of Mr. Kenny's Amended and Restated Employment Agreement."}],"balance_after":198119,"derivative":{"exercise_price":10.1,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":198119},"source":{"system":"sec-edgar","filing":"0001127602-19-032143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219032143/form4.xml","form_type":"4"}},{"id":3378095,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-11-07T15:03:35.000Z","date":"2019-11-05","kind":"grant","acquired":true,"shares":99505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award is made under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019.  The restricted stock units vest in full (100%) on October 1, 2022."}],"balance_after":178324,"source":{"system":"sec-edgar","filing":"0001127602-19-032143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219032143/form4.xml","form_type":"4"}},{"id":3393948,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-10-15T09:29:31.000Z","date":"2019-10-11","kind":"tax_withholding","acquired":false,"shares":4181,"price":8.83,"value":36918.23,"ownership":{"direct":true},"balance_after":78819,"source":{"system":"sec-edgar","filing":"0001127602-19-030443","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219030443/form4.xml","form_type":"4"}},{"id":3534256,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-09T12:40:45.000Z","date":"2019-05-08","kind":"purchase","acquired":true,"shares":20000,"price":11.4872,"value":229744.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Prices range from $11.4410 per share to $11.5100 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0001127602-19-017855","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219017855/form4.xml","form_type":"4"}},{"id":3760071,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-11-19T12:48:03.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021."}],"balance_after":63000,"source":{"system":"sec-edgar","filing":"0001127602-18-033646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760218033646/form4.xml","form_type":"4"}},{"id":4166687,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-11-13T15:41:53.000Z","date":"2017-11-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001127602-17-031881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760217031881/form4.xml","form_type":"4"}},{"id":4188497,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-11T19:07:29.000Z","date":"2017-10-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest in four equal annual installments from the date of grant (i.e., 25% per year until fully vested on October 9, 2021)."}],"balance_after":100000,"derivative":{"exercise_price":14.5,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-17-024070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000089924317024070/doc4.xml","form_type":"4"}},{"id":4188496,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":41076,"kind":"person","name":"Kenny John P.","position":1,"cik":"0001719325","reported_name":"Kenny John P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-10-11T19:07:29.000Z","date":"2017-10-09","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock units vest in full on October 9, 2019."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0000899243-17-024070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000089924317024070/doc4.xml","form_type":"4"}}]}